Dishman Carbogen

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE385W01011
  • NSEID: DCAL
  • BSEID: 540701
INR
244.35
-20.3 (-7.67%)
BSENSE

Dec 18

BSE+NSE Vol: 7.72 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002833,
    "name": "Dishman Carbogen",
    "stock_name": "Dishman Carbogen",
    "full_name": "Dishman Carbogen Amcis Ltd",
    "name_url": "stocks-analysis/dishman-carbogen",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "244.35",
    "chg": -20.3,
    "chgp": "-7.67%",
    "dir": -1,
    "prev_price": "264.65",
    "mcapval": "3,958.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540701,
    "symbol": "DCAL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE385W01011",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "7.72 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dishman-carbogen-1002833-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dishman Carbogen Amcis Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-hits-intraday-low-amid-price-pressure-on-18-dec-2025-3762731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_priceRelatedfactors_3762731.png",
        "date": "2025-12-18 13:38:42",
        "description": "Dishman Carbogen Amcis experienced a notable intraday decline, touching a low of Rs 245.65, reflecting a 7.18% reduction in value. This downturn contrasts with the broader market's modest gains, highlighting immediate pressures on the stock within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Dishman Carbogen Amcis Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dishman-carbogen-amcis-upgraded-to-hold-on-technical-and-valuation-improvements-3762044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_mojoScore_3762044.png",
        "date": "2025-12-18 08:19:39",
        "description": "Dishman Carbogen Amcis, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by evolving technical indicators and a complex financial backdrop. This article examines the recent changes across quality, valuation, financial trends, and technical parameters that have influenced the company’s current standing."
      },
      {
        "title": "Dishman Carbogen Amcis Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-shows-technical-momentum-shift-amid-mixed-market-returns-3761987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_technicaldot_3761987.png",
        "date": "2025-12-18 08:13:50",
        "description": "Dishman Carbogen Amcis has experienced a notable shift in price momentum, reflected in a range of technical indicators that suggest a nuanced market assessment. The stock’s recent trading activity, combined with changes in key metrics such as MACD, RSI, and moving averages, highlights a complex interplay between bullish and bearish signals within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Dishman Carbogen Amcis Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-hits-intraday-high-with-1245-surge-on-17-dec-2025-3761428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_priceRelatedfactors_3761428.png",
        "date": "2025-12-17 14:33:14",
        "description": "Dishman Carbogen Amcis demonstrated robust intraday performance on 17 Dec 2025, reaching a day’s high of Rs 242.6, reflecting a 5.2% rise during trading hours and outperforming its sector by 4.35% amid a broadly subdued market environment."
      },
      {
        "title": "Why is Dishman Carbogen falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dishman-carbogen-fallingrising-3749628",
        "imagepath": "",
        "date": "2025-12-06 01:35:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Dishman Carbogen’s shares have experienced a notable decline over the past week, falling by 6.47%, while the benchmark Sensex remained virtually flat with a marginal gain of 0.01%. This underperformance extends over longer periods, with the stock down 24.62% in the last month and 17.34% year-to-date, contrasting sharply with the Sensex’s positive returns of 2.70% and 9.69% respectively. Over the past year, the stock has declined by 15.46%, whereas the Sensex gained 4.83%. Despite this, the company’s three-year returns remain robust at 124.34%, outperforming the Sensex’s 36.41% over the same period, though the five-year returns of 53.53% lag behind the benchmark’s 90.14%.</p>\n<p>On 05-Dec, the stock underperformed its sector by 1.8%..."
      },
      {
        "title": "Dishman Carbogen Amcis Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-faces-mildly-bearish-momentum-amid-technical-downgrade-3742970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_technicaldot_3742970.png",
        "date": "2025-12-03 08:08:09",
        "description": "Dishman Carbogen Amcis, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments indicate a transition from a sideways trend to a mildly bearish stance, underscoring the nuanced signals from various technical indicators."
      },
      {
        "title": "Dishman Carbogen Amcis: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dishman-carbogen-amcis-downgraded-to-sell-amid-mixed-fundamentals-and-technical-weakness-3740733",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_mojoScore_3740733.png",
        "date": "2025-12-02 08:51:26",
        "description": "Dishman Carbogen Amcis, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s analytical perspective, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Dishman Carbogen Amcis Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-faces-technical-momentum-shift-amid-mixed-market-signals-3740320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DishmanCarbogen_technicaldot_3740320.png",
        "date": "2025-12-02 08:11:12",
        "description": "Dishman Carbogen Amcis, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a notable shift in its technical momentum as recent evaluation adjustments reflect a transition from mildly bullish to sideways trends. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term trajectory."
      },
      {
        "title": "How has been the historical performance of Dishman Carbogen?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dishman-carbogen-3739337",
        "imagepath": "",
        "date": "2025-12-01 23:27:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance</strong></p>\n<p>Over the seven-year period ending March 2025, Dishman Carbogen’s net sales demonstrated a generally upward trend, increasing from ₹2,058.60 crores in 2019 to ₹2,711.50 crores in 2025. This represents a compound growth trajectory, with notable acceleration from 2021 onwards. Total operating income mirrored this pattern, reflecting the absence of other operating income throughout the period.</p>\n<p>Operating profit before depreciation, interest, and tax (PBDIT) excluding other income showed volatility. It declined from ₹551.90 crores in 2019 to a low of ₹274.35 crores in 2021, before recovering to ₹468.94 crores in 2025. Including other income, operating profit (PBDIT) followed a similar pattern, peaking at ₹605.72 crores in 2019 and dipping to..."
      }
    ],
    "total": 851,
    "sid": "1002833",
    "stock_news_url": "https://www.marketsmojo.com/news/dishman-carbogen-amcis-1002833"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "12-Nov-2025",
      "details": "Pls. find enclosed herewith Press Release under Regulations 30 and 51 of the SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "11-Nov-2025",
      "details": "PFA transcript of Con Call held on 05.11.2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Nov-2025",
      "details": "Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 the audio recording of Conference Call arranged by the Company with Investors on Wednesday 5th November 2025 which was commenced at 15:00 hrs. (IST) to discuss the financial result and performance of the Company for the second quarter and half year ended on 30th September 2025 is available on the Companys website at https://imdcal.com/ir-index.php?Investor%20Call%20Recording%20and%20Transcript/Audio-Video%20Recording/2025-26#Q2%20FY2025-26%20Result-Audio%20Recording-05.11.2025.mp3",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dishman Carbogen Amcis Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 19",
          "dt": "2019-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Dishman Carbogen falling/rising?

2025-12-06 01:35:40

Recent Price Movement and Market Performance

Dishman Carbogen’s shares have experienced a notable decline over the past week, falling by 6.47%, while the benchmark Sensex remained virtually flat with a marginal gain of 0.01%. This underperformance extends over longer periods, with the stock down 24.62% in the last month and 17.34% year-to-date, contrasting sharply with the Sensex’s positive returns of 2.70% and 9.69% respectively. Over the past year, the stock has declined by 15.46%, whereas the Sensex gained 4.83%. Despite this, the company’s three-year returns remain robust at 124.34%, outperforming the Sensex’s 36.41% over the same period, though the five-year returns of 53.53% lag behind the benchmark’s 90.14%.

On 05-Dec, the stock underperformed its sector by 1.8%...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12-Nov-2025 | Source : BSE

Pls. find enclosed herewith Press Release under Regulations 30 and 51 of the SEBI (LODR) Regulations 2015.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

11-Nov-2025 | Source : BSE

PFA transcript of Con Call held on 05.11.2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

05-Nov-2025 | Source : BSE

Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 the audio recording of Conference Call arranged by the Company with Investors on Wednesday 5th November 2025 which was commenced at 15:00 hrs. (IST) to discuss the financial result and performance of the Company for the second quarter and half year ended on 30th September 2025 is available on the Companys website at https://imdcal.com/ir-index.php?Investor%20Call%20Recording%20and%20Transcript/Audio-Video%20Recording/2025-26#Q2%20FY2025-26%20Result-Audio%20Recording-05.11.2025.mp3

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Dishman Carbogen Amcis Ltd has declared 10% dividend, ex-date: 12 Sep 19

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available